# CardioGenics Inc.: Form D filing

CardioGenics Inc., a biotechnology company in Mississauga, filed a Form D with the SEC in 2009. The latest, on August 17, 2009, reports $2.7 million sold of a $2.7 million offering to 16 investors.

Find out what CardioGenics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CardioGenics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CardioGenics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcardiogenics-inc-1470449)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CardioGenics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CardioGenics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcardiogenics-inc-1470449)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6295 NORTHAM DRIVE, UNIT 8, Mississauga, L4V 1
- Phone: (905) 673-8501
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Ontario, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1470449

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 17, 2009 | New notice | $2,715,000 | $2,715,000 | $0 | 16 | Jul 31, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1470449/000120445909001516/0001204459-09-001516-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David Carville | Executive Officer |  |
| Yahia Gawad | Executive Officer, Director |  |
| Alexander Reid | Director |  |
| Chandra Panchal | Director |  |
| James Essex | Executive Officer |  |
| J. Neil Tabatznik | Director |  |
| Linda J. Sterling | Executive Officer, Director |  |

[Every Form D from the week of Aug 17, 2009](https://specstream.ai/data/form-d/week/2009-08-17) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CardioGenics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).